The largest database of trusted experimental protocols

4 protocols using 6230 esi tof ms

1

Synthetic Honaucin A Bioassay and Chemical Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synthetic honaucin A was used in all assays and measurements. For bioassays, lipopolysacchar-ides from Escherichia coli (O26:B6) as well as phorbol 12-myristate 13-acetate and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide were purchased from Sigma-Aldrich (St. Louis, MO). NRF2 luciferase reporter MCF7 stable cells were purchased from Signosis (Santa Clara, CA). RNA sequencing was carried out using an Illumina Hiseq2000 (San Diego, CA) following RNA quality assessment via Bioanalyzer 2100 (Agilent, Santa Clara, CA). For in vitro alkylation experiments, reaction products were separated via liquid chromatography using a Phenomenex Kinetex 5 μm EVO C-18 column. Highresolution mass analysis was accomplished with an Agilent 6230 ESI-TOF-MS operating in positive mode.
+ Open protocol
+ Expand
2

Reaction of Honaucin A with N-Acetyl-L-cysteine

Check if the same lab product or an alternative is used in the 5 most similar protocols
N-Acetyl-L-cysteine (NAC, Spectrum Chemical) was dissolved in milli-Q water, and synthetic honaucin A was solubilized in DMSO. Honaucin A was incubated with NAC in either 2-or 50-fold excess with stirring under argon for 2 h at room temperature (after Wang et al., 2013).22 (link) At the conclusion of the reaction, vial contents were passed over a Bond Elut-C18 SPE column (Agilent) that had been washed with 3 column volumes of methanol and then equilibrated with 3 column volumes of water. The reaction products were subsequently eluted with increasing percentages of methanol. Elutions were dried using rotary evaporation and then reconstituted at a concentration of 1 mg/mL in 50:50 methanol/water. This preparation was analyzed for the presence of the hypothesized addition products via high-resolution MS at the Molecular Mass Spectrometry Facility at the University of California, San Diego. Briefly, reaction products were separated via liquid chromatography using a Phenomenex Kinetex 5 μm EVO C-18 column prior to being introduced to an Agilent 6230 ESI-TOF-MS running in positive mode for high-resolution mass measurement.
+ Open protocol
+ Expand
3

Characterization of Organic Compounds via Spectroscopic Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals, unless otherwise stated, were purchased from Sigma Aldrich and used as received. Cuprisorb resin was purchased from SeaChem Labs. Reaction progress was monitored by analytical thin-layer chromatography (TLC, Merck silica gel plates) with UV illumination or via CAM, ninhydrin, or KMnO4 staining. Column chromatography was performed on a Biotage Isolera One automated flash chromatography system. Nuclear magnetic resonance (1H and 13C NMR) spectra were recorded on Bruker 300 MHz and Jeol 500 MHz NMR spectrometers. Spectra were recorded in CDCl3 or D2O at 293 K and are reported in parts per million (ppm) on the δ scale relative to residual solvent as an internal standard (for 1H NMR: CDCl3 = 7.26 ppm, D2O = 4.79 ppm, for 13C NMR: CDCl3 = 77.0 ppm, CD3OD = 49.0 ppm). HRMS (high-resolution mass spectrometry) analysis was performed on an Agilent 6230 ESI-TOFMS in positive ion mode. UV-Vis spectra were collected in a quartz cuvette using a Thermo Scientific Nanodrop2000c spectrophotometer. IR spectroscopy was performed on a Nicolet 6700 FT-IR spectrophotometer. Size exclusion chromatography (SEC) was performed on a Hitachi Chromaster system equipped with an RI detector and two 5 μm, mixed bed, 7.8 mm I.D. × 30 cm TSK gel columns in series (Tosoh Bioscience) using an isocratic method with a flow rate of 0.7 mL min−1 in DMF (0.2% LiBr, 70 °C).
+ Open protocol
+ Expand
4

Solid-Phase Peptide Synthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All peptides were synthesized using Fmoc/t-Bu Solid-Phase Peptide Synthesis (27 (link)). Six peptides were synthesized using Rink Amide resin on a Liberty Blue peptide synthesizer (CEM Corp); 31 peptides were synthesized on a Prelude peptide synthesizer (PTI); five peptides were synthesized manually as detailed in the Supplementary information. The remaining ten peptides were purchased from Shanghai Royobiotech at >95% purity. Synthesized peptides were purified using semipreparatory RP-HPLC using a Phenomenex Luna C18(2) or Phenomenex Aeris Peptide C18 column (10 mm × 250 mm, 5 μm) over a linear gradient of water and acetonitrile, with 0.1% TFA, at 4 ml/min and UV detection at 220 nm. Peptide identity was confirmed by high resolution mass spectrometry using an Agilent 6230 ESI-TOF MS. Peptide purity was characterized on an Agilent 1260 Infinity analytical RP-HPLC equipped with a Phenomenex Luna C18(2) column (4.6 mm × 250 mm, 5 μm) using a linear gradient of 0 to 50% acetonitrile with 0.1% TFA and in water with 0.1% TFA, over 15 min at 1.5 ml/min and visualized at 220 nm. Detailed methods are included in the Electronic Supplementary Information and characterization data are listed in Table S1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!